AU Stock MarketDetailed Quotes

ATH Alterity Therapeutics Ltd

Watchlist

0.003
-0.001-25.00%

20min DelayTrading Nov 13 10:18 AET

15.74MMarket Cap-600P/E (Static)

Alterity Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Sep 30, 2024

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

Operating cash flow (direct method)

Cash income from operating activities

3.91M

4.68M

Revenue from customers

--0

----

--0

----

--0

----

Income from government grants

--0

----

--3.91M

--0

--4.68M

----

--0

----

Cash paid

19.80%-3.38M

-67.05%-6.53M

-4.88M

11.62%-4.21M

-7.31%-3.91M

Cash paid on behalf of employees

4.94%-789K

----

25.60%-872K

---922K

8.59%-830K

----

-30.80%-1.17M

----

Other cash payments from operating activities

23.45%-2.59M

----

-106.77%-5.65M

---3.96M

9.96%-3.38M

----

0.36%-2.73M

----

Direct dividend received

--0

----

--0

----

--0

----

Direct interest paid

--0

----

--0

----

--0

----

Direct interest received

-9.76%74K

----

2,050.00%43K

--17K

--82K

----

--2K

----

Direct tax refund paid

--0

----

--0

----

--0

----

Operating cash flow

-702.00%-3.31M

----

33.99%-2.58M

---4.86M

111.52%549K

----

-14.42%-3.9M

----

Investing cash flow

Cash flow from continuing investing activities

84.31%-5.72K

97.28%-722

79.50%-1K

-4K

59.10%-36.46K

70.18%-26.58K

-5K

-90.58%-4.88K

Net PPE purchase and sale

--0

21.73%-5.72K

-128.14%-722

--0

79.50%-1K

---4K

91.80%-7.31K

102.88%2.57K

---5K

-90.58%-4.88K

Net intangibles purchas and sale

--0

----

--0

----

--0

----

Net business purchase and sale

--0

----

--0

----

--0

----

Net investment purchase and sale

--0

----

--0

----

--0

----

Dividends received (cash flow from investment activities)

----

--0

----

--0

----

Net other investing changes

----

---29.15K

----

Cash from discontinued investing activities

Investing cash flow

--0

84.31%-5.72K

97.28%-722

--0

79.50%-1K

---4K

59.10%-36.46K

70.18%-26.58K

---5K

-90.58%-4.88K

Financing cash flow

Cash flow from continuing financing activities

-317.65%-71K

7,312.17%9.22M

196.32%12.29K

6,501.60%8.25M

990.74%970K

-114.05%-17K

-99.24%124.34K

95.53%-12.76K

12,400.00%125K

59.51%-108.9K

Net issuance payments of debt

--0

82.69%-10.37K

67.75%-10.37K

--0

-73.62%-59.92K

6.84%-32.15K

--0

-16.89%-27.77K

Net common stock issuance

--0

3,103.50%10.14M

1,523.21%94.68K

4,803.30%8.92M

712,758.23%1.13M

--0

-98.16%316.68K

14,482.50%5.83K

--182K

-495.00%-158

Cash dividends paid

--0

----

--0

----

--0

----

Proceeds from stock option exercised by employees

--0

----

--0

----

--0

----

Net other financing activities

-317.65%-71K

-593.30%-918.02K

-631.16%-72.02K

-1,080.70%-673K

-92.66%-156K

-112.50%-17K

84.18%-132.41K

105.40%13.56K

-5,800.00%-57K

66.98%-80.97K

Cash from discontinued financing activities

Financing cash flow

-317.65%-71K

7,312.17%9.22M

196.32%12.29K

6,500.80%8.25M

990.74%970K

-114.05%-17K

-99.24%124.34K

95.53%-12.76K

12,400.00%125K

59.51%-108.9K

Net cash flow

Beginning cash position

-19.87%12.64M

-54.68%15.77M

-16.60%18.3M

-51.40%12.32M

-47.54%16.71M

-54.68%15.77M

23.80%34.81M

-32.76%21.94M

-31.49%25.35M

-22.95%31.85M

Current changes in cash

-739.39%-3.38M

82.98%-3.4M

8.71%-5.7M

249.95%5.67M

26.14%-3.89M

111.37%528K

-614.37%-19.95M

-1,645.52%-6.25M

-10.94%-3.78M

-30.23%-5.27M

Effect of exchange rate changes

-95.10%20K

-71.54%260.36K

-55.33%39.36K

-18.78%307K

60.05%-495K

-75.83%408K

-67.48%914.94K

-96.52%88.1K

139.54%378K

-336.73%-1.24M

End cash Position

-44.44%9.28M

-19.87%12.64M

-16.60%18.3M

-51.38%12.32M

-47.54%16.71M

-54.68%15.77M

-32.76%21.94M

-31.52%25.34M

Free cash from

-706.42%-3.31M

37.08%-12.61M

7.90%-5.71M

34.08%-2.58M

5.80%-4.86M

111.44%545K

-61.29%-20.04M

-8,467.47%-6.2M

-14.57%-3.91M

-36.58%-5.16M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Sep 30, 2024	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022
Operating cash flow (direct method)
Cash income from operating activities				3.91M	0	4.68M
Revenue from customers	--0	----	----	--0	--0	--0	----	----	--0	----
Income from government grants	--0	----	----	--3.91M	--0	--4.68M	----	----	--0	----
Cash paid	19.80%-3.38M			-67.05%-6.53M	-4.88M	11.62%-4.21M			-7.31%-3.91M
Cash paid on behalf of employees	4.94%-789K	----	----	25.60%-872K	---922K	8.59%-830K	----	----	-30.80%-1.17M	----
Other cash payments from operating activities	23.45%-2.59M	----	----	-106.77%-5.65M	---3.96M	9.96%-3.38M	----	----	0.36%-2.73M	----
Direct dividend received	--0	----	----	--0	--0	--0	----	----	--0	----
Direct interest paid	--0	----	----	--0	--0	--0	----	----	--0	----
Direct interest received	-9.76%74K	----	----	2,050.00%43K	--17K	--82K	----	----	--2K	----
Direct tax refund paid	--0	----	----	--0	--0	--0	----	----	--0	----
Operating cash flow	-702.00%-3.31M	----	----	33.99%-2.58M	---4.86M	111.52%549K	----	----	-14.42%-3.9M	----
Investing cash flow
Cash flow from continuing investing activities	0	84.31%-5.72K	97.28%-722	0	79.50%-1K	-4K	59.10%-36.46K	70.18%-26.58K	-5K	-90.58%-4.88K
Net PPE purchase and sale	--0	21.73%-5.72K	-128.14%-722	--0	79.50%-1K	---4K	91.80%-7.31K	102.88%2.57K	---5K	-90.58%-4.88K
Net intangibles purchas and sale	--0	----	----	--0	--0	--0	----	----	--0	----
Net business purchase and sale	--0	----	----	--0	--0	--0	----	----	--0	----
Net investment purchase and sale	--0	----	----	--0	--0	--0	----	----	--0	----
Dividends received (cash flow from investment activities)	----	----	----	--0	--0	--0	----	----	--0	----
Net other investing changes	----	----	----	----	----	----	---29.15K	----	----	----
Cash from discontinued investing activities
Investing cash flow	--0	84.31%-5.72K	97.28%-722	--0	79.50%-1K	---4K	59.10%-36.46K	70.18%-26.58K	---5K	-90.58%-4.88K
Financing cash flow
Cash flow from continuing financing activities	-317.65%-71K	7,312.17%9.22M	196.32%12.29K	6,501.60%8.25M	990.74%970K	-114.05%-17K	-99.24%124.34K	95.53%-12.76K	12,400.00%125K	59.51%-108.9K
Net issuance payments of debt	--0	82.69%-10.37K	67.75%-10.37K	--0	--0	--0	-73.62%-59.92K	6.84%-32.15K	--0	-16.89%-27.77K
Net common stock issuance	--0	3,103.50%10.14M	1,523.21%94.68K	4,803.30%8.92M	712,758.23%1.13M	--0	-98.16%316.68K	14,482.50%5.83K	--182K	-495.00%-158
Cash dividends paid	--0	----	----	--0	--0	--0	----	----	--0	----
Proceeds from stock option exercised by employees	--0	----	----	--0	--0	--0	----	----	--0	----
Net other financing activities	-317.65%-71K	-593.30%-918.02K	-631.16%-72.02K	-1,080.70%-673K	-92.66%-156K	-112.50%-17K	84.18%-132.41K	105.40%13.56K	-5,800.00%-57K	66.98%-80.97K
Cash from discontinued financing activities
Financing cash flow	-317.65%-71K	7,312.17%9.22M	196.32%12.29K	6,500.80%8.25M	990.74%970K	-114.05%-17K	-99.24%124.34K	95.53%-12.76K	12,400.00%125K	59.51%-108.9K
Net cash flow
Beginning cash position	-19.87%12.64M	-54.68%15.77M	-16.60%18.3M	-51.40%12.32M	-47.54%16.71M	-54.68%15.77M	23.80%34.81M	-32.76%21.94M	-31.49%25.35M	-22.95%31.85M
Current changes in cash	-739.39%-3.38M	82.98%-3.4M	8.71%-5.7M	249.95%5.67M	26.14%-3.89M	111.37%528K	-614.37%-19.95M	-1,645.52%-6.25M	-10.94%-3.78M	-30.23%-5.27M
Effect of exchange rate changes	-95.10%20K	-71.54%260.36K	-55.33%39.36K	-18.78%307K	60.05%-495K	-75.83%408K	-67.48%914.94K	-96.52%88.1K	139.54%378K	-336.73%-1.24M
End cash Position	-44.44%9.28M	-19.87%12.64M	-19.87%12.64M	-16.60%18.3M	-51.38%12.32M	-47.54%16.71M	-54.68%15.77M	-54.68%15.77M	-32.76%21.94M	-31.52%25.34M
Free cash from	-706.42%-3.31M	37.08%-12.61M	7.90%-5.71M	34.08%-2.58M	5.80%-4.86M	111.44%545K	-61.29%-20.04M	-8,467.47%-6.2M	-14.57%-3.91M	-36.58%-5.16M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data